AlphAIalphai — Financial news for AI agents
Stock TitanMAR 41 min read$BCYC

Westfield reports 0 shares in Bicycle Therapeutics (NASDAQ: BCYC)

Westfield Capital Management Company, L.P. filed an Amendment No. 2 to a Schedule 13G, reporting that it beneficially owned 0 shares of Bicycle Therapeutics plc (NASDAQ: BCYC) common stock as of December 31, 2025. The filing indicates no voting or dispositive power held by Westfield for BCYC shares. The amendment was signed by Brandi McMahon, Vice President, Deputy Chief Compliance Officer, and dated March 3, 2026.

Original reporting
Stock Titan
Published Mar 4, 2026, 1:53 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 4, 2026, 2:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$BCYC
Neutral
high confidence
Mentioned
$BCYC
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$BCYCNeutralLow
01

Why it matters

This update suggests no active investment or influence in BCYC, implying limited market impact.

02

Market read

The news has minimal relevance to the biotech or financial markets, given the lack of ownership change.

03

What to watch

The news may reflect portfolio rebalancing or passive investment strategies, not necessarily negative sentiment.

Timing: low

Background

Westfield Capital Management filed an amendment to its Schedule 13G, indicating it beneficially owns no shares of Bicycle Therapeutics as of December 31, 2025.

Company-level read

Ticker impact

$BCYCNeutralHigh confidence
Context

Minimal impact due to zero ownership stake.

Expected impact

No significant price movement expected in BCYC stock.

Evidence & confidence

The report explicitly states Westfield owns zero shares and holds no voting or dispositive power, indicating no direct influence or market signal.

Market effects

Sector

Limited, as the news does not affect Bicycle Therapeutics' operational outlook.

Regional

None expected.

Global

Negligible.

Counterpoint

What could challenge this read

Some investors might interpret the zero ownership as a sign of strategic disengagement, potentially negative if perceived as lack of confidence.

Key entities

  • Investment Management Firm
    Westfield Capital Management Company, L.P.

    A major investment management firm that filed the amendment.

  • Biotech Company
    Bicycle Therapeutics plc

    The subject of the filing, with no current ownership by Westfield.

Read at source← All news

Related articles

JUL 30
$BCYCMed

Bicycle Therapeutics plc: Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results

Bicycle Therapeutics (NASDAQ: BCYC) reported Q2 2026 results and business updates. It cited AACR/ASCO data for nuzefatide in EphA2-expressing cancers, including Phase 2 recurrent pancreatic cancer with first patient dosed in April 2026. Cash was $510.1M at June 30, 2026, funding into 2030. Duravelo-2 interim Week 27 ORR was 65% (17/26).

finanznachrichten.de6 min
JUL 30
$BCYCMed

BICYCLE THERAPEUTICS PLC (BCYC): Results of Operations and Financial Condition

BICYCLE THERAPEUTICS PLC (BCYC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2621593d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results Data presented at AACR and ASCO provide further validation of the potential of Bicycle ® technology to deliver oncology thera

SEC EDGAR 8-K6 min
AUG 9
$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

baystreet.ca3 min
AUG 9
$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

tradearabia.com3 min
AUG 9
$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

globes.co.il4 min
AUG 9
$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.

ua.news5 min